We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Maravai LifeSciences Holdings Inc | NASDAQ:MRVI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.12 | 1.58% | 7.70 | 6.99 | 13.27 | 7.82 | 7.50 | 7.61 | 1,260,217 | 05:00:04 |
FORM 8-K | ||||||||
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
||||||||
Date of Report (Date of earliest event reported): May 10, 2021 | ||||||||
Delaware
(State or other jurisdiction
of incorporation)
|
001-39725
(Commission
File Number)
|
85-2786970
(IRS Employer
Identification No.)
|
||||||||||||
10770 Wateridge Circle Suite 200
San Diego, California
(Address of principal executive offices)
|
92121
(Zip Code)
|
|||||||||||||
(858) 546-0004
(Registrant’s telephone number, including area code)
|
||||||||||||||
Not Applicable
(Former name or former address, if changed since last report.)
|
||||||||||||||
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class |
Trading
Symbol(s) |
Name of each exchange
on which registered |
||||||||||||
Class A Common Stock, $0.01 par value | MRVI | The Nasdaq Stock Market LLC (Nasdaq Global Select Market) |
☒ | Emerging growth company | ||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisited financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |
Exhibit
No. |
Description of Exhibit | |||||||
99.1 |
MARAVAI LIFESCIENCES HOLDINGS, INC. | ||||||||
Date: May 10, 2021 | By: | /s/ Kevin M. Herde | ||||||
Name: | Kevin M. Herde | |||||||
Title: | Chief Financial Officer |
1 Year Maravai LifeSciences Chart |
1 Month Maravai LifeSciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions